{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:39:31Z","timestamp":1793673571618,"version":"4.5.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073777"],"award-info":[{"award-number":["82073777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Melanoma is the most serious type of skin cancer, and surgery is an effective method to treat melanoma. Unfortunately, local residual micro-infiltrated tumour cells and systemic circulating tumour cells (CTCs) are significant causes of treatment failure, leading to tumour recurrence and metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Small EVs were isolated from platelets by differential centrifugation, and doxorubicin-loaded small EVs (PexD) was prepared by mixing small EVs with doxorubicin (DOX). PexD and an anti-PD-L1 monoclonal antibody (aPD-L1) were co-encapsulated in fibrin gel. The synergistic antitumour efficacy of the gel containing PexD and aPD-L1 was assessed both in vitro and in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Herein, we developed an in situ-formed bioresponsive gel combined with chemoimmunotherapeutic agents as a drug reservoir that could effectively inhibit both local tumour recurrence and tumour metastasis. In comparison with a DOX solution, PexD could better bind to tumour cells, induce more tumour immunogenic cell death (ICD) and promote a stronger antitumour immune response. PexD could enter the blood circulation through damaged blood vessels to track and eliminate CTCs. The concurrent release of aPD-L1 at the tumour site could impair the PD-1\/PD-L1 pathway and restore the tumour-killing effect of cytotoxic T cells. This chemoimmunotherapeutic strategy triggered relatively strong T cell immune responses, significantly improving the tumour immune microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicated that the immunotherapeutic fibrin gel could \u201cawaken\u201d the host innate immune system to inhibit both local tumour recurrence post-surgery and metastatic potential, thus, it could serve as a promising approach to prevent tumour recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-022-01270-7","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T15:53:52Z","timestamp":1643817232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs"],"prefix":"10.1186","volume":"20","author":[{"given":"Jian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5470-1599","authenticated-orcid":false,"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"1270_CR1","doi-asserted-by":"publisher","first-page":"e000415","DOI":"10.1136\/jitc-2019-000415","volume":"8","author":"J Ahmed","year":"2020","unstructured":"Ahmed J, Chard LS, Yuan M, Wang J, Howells A, Li Y, et al. A new oncolytic Vaccinia virus augments antitumour immune responses to prevent tumour recurrence and metastasis after surgery. J Immunother Cancer. 2020;8:e000415.","journal-title":"J Immunother Cancer"},{"key":"1270_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s41591-020-1082-2","volume":"26","author":"R Dummer","year":"2020","unstructured":"Dummer R, Lebb\u00e9 C, Atkinson V, Mandal\u00e0 M, Nathan PD, Arance A, et al. Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i. Nat Med. 2020;26:1557\u201363.","journal-title":"Nat Med"},{"key":"1270_CR3","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1038\/s41467-020-19810-w","volume":"11","author":"A Ribas","year":"2020","unstructured":"Ribas A, Algazi A, Ascierto PA, Butler MO, Chandra S, Gordon M, et al. PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nat Commun. 2020;11:6262.","journal-title":"Nat Commun"},{"key":"1270_CR4","doi-asserted-by":"publisher","first-page":"159ra149","DOI":"10.1126\/scitranslmed.3004599","volume":"4","author":"E Quintana","year":"2012","unstructured":"Quintana E, Piskounova E, Shackleton M, Weinberg D, Eskiocak U, Fullen DR, et al. Human melanoma metastasis in NSG mice correlates with clinical outcome in patients. Sci Transl Med. 2012;4:159ra149.","journal-title":"Sci Transl Med"},{"key":"1270_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccell.2020.11.005","volume":"39","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Furlan SN, Jaeger-Ruckstuhl CA, Sarvothama M, Berger C, Smythe KS, et al. Immunogenic chemotherapy enhances recruitment of CAR-T cells to lung tumours and improves antitumour efficacy when combined with checkpoint blockade. Cancer Cell. 2021;39:193-208.e10.","journal-title":"Cancer Cell"},{"key":"1270_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.024","volume":"206","author":"H Ye","year":"2019","unstructured":"Ye H, Wang K, Wang M, Liu R, Song H, Li N, et al. Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition. Biomaterials. 2019;206:1\u201312.","journal-title":"Biomaterials"},{"key":"1270_CR7","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.3390\/ijms20174185","volume":"20","author":"K Kojok","year":"2019","unstructured":"Kojok K, El-Kadiry AE, Merhi Y. Role of NF-\u03baB in platelet function. Int J Mol Sci. 2019;20:4185.","journal-title":"Int J Mol Sci"},{"key":"1270_CR8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/neuonc\/noab046","volume":"23","author":"CAC Jessurun","year":"2021","unstructured":"Jessurun CAC, Hulsbergen AFC, de Wit AE, Tewarie IA, Snijders TJ, Verhoeff JJC, et al. The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis. Neuro Oncol. 2021;23:1261\u201372.","journal-title":"Neuro Oncol"},{"key":"1270_CR9","doi-asserted-by":"publisher","first-page":"e2007051","DOI":"10.1002\/smll.202007051","volume":"17","author":"W Zhao","year":"2021","unstructured":"Zhao W, Hu X, Li W, Li R, Chen J, Zhou L, et al. M2-Like TAMs function reversal contributes to breast cancer eradication by combination dual immune checkpoint blockade and photothermal therapy. Small. 2021;17:e2007051.","journal-title":"Small"},{"key":"1270_CR10","doi-asserted-by":"publisher","first-page":"eabd8636","DOI":"10.1126\/scitranslmed.abd8636","volume":"13","author":"JA Lo","year":"2021","unstructured":"Lo JA, Kawakubo M, Juneja VR, Su MY, Erlich TH, LaFleur MW, et al. Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses. Sci Transl Med. 2021;13:eabd8636.","journal-title":"Sci Transl Med"},{"key":"1270_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/M20-3419","volume":"174","author":"MK van der Kooij","year":"2021","unstructured":"van der Kooij MK, Suijkerbuijk KPM, Aarts MJB, van den Berkmortel F, Blank CU, Boers-Sonderen MJ, et al. Safety and efficacy of checkpoint inhibition in patients with melanoma and preexisting autoimmune disease\u202f: a cohort study. Ann Intern Med. 2021;174:641\u20138.","journal-title":"Ann Intern Med"},{"key":"1270_CR12","doi-asserted-by":"publisher","first-page":"119659","DOI":"10.1016\/j.biomaterials.2019.119659","volume":"230","author":"X Dong","year":"2020","unstructured":"Dong X, Yang A, Bai Y, Kong D, Lv F. Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumour microenvironment for effective chemo-immunotherapy. Biomaterials. 2020;230:119659.","journal-title":"Biomaterials"},{"key":"1270_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.biomaterials.2019.04.024","volume":"209","author":"X Dong","year":"2019","unstructured":"Dong X, Liang J, Yang A, Qian Z, Kong D, Lv F. Fluorescence imaging guided CpG nanoparticles-loaded IR820-hydrogel for synergistic photothermal immunotherapy. Biomaterials. 2019;209:111\u201325.","journal-title":"Biomaterials"},{"key":"1270_CR14","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1021\/acs.nanolett.1c00977","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang Z, Chen B, Yin Q, Pan M, Xia H, et al. Cooperative self-assembled nanoparticle induces sequential immunogenic cell death and toll-like receptor activation for synergistic chemo-immunotherapy. Nano Lett. 2021;21:4371\u201380.","journal-title":"Nano Lett"},{"key":"1270_CR15","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1021\/acsnano.0c09681","volume":"15","author":"M Hu","year":"2021","unstructured":"Hu M, Zhang J, Kong L, Yu Y, Hu Q, Yang T, et al. Immunogenic hybrid nanovesicles of liposomes and tumour-derived nanovesicles for cancer immunochemotherapy. ACS Nano. 2021;15:3123\u201338.","journal-title":"ACS Nano"},{"key":"1270_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","volume":"3","author":"S Senapati","year":"2018","unstructured":"Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3:7.","journal-title":"Signal Transduct Target Ther"},{"key":"1270_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-021-01312-y","volume":"20","author":"MY Li","year":"2021","unstructured":"Li MY, Liu LZ, Dong M. Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. Mol Cancer. 2021;20:22.","journal-title":"Mol Cancer"},{"key":"1270_CR18","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.3390\/ijms22115967","volume":"22","author":"A Georgescu","year":"2021","unstructured":"Georgescu A, Simionescu M. Extracellular vesicles: versatile nanomediators, potential biomarkers and therapeutic agents in atherosclerosis and COVID-19-related thrombosis. Int J Mol Sci. 2021;22:5967.","journal-title":"Int J Mol Sci"},{"key":"1270_CR19","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11:3183\u201395.","journal-title":"Theranostics"},{"key":"1270_CR20","doi-asserted-by":"publisher","first-page":"120224","DOI":"10.1016\/j.biomaterials.2020.120224","volume":"257","author":"K Wang","year":"2020","unstructured":"Wang K, Ye H, Zhang X, Wang X, Yang B, Luo C, et al. An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Biomaterials. 2020;257:120224.","journal-title":"Biomaterials"},{"key":"1270_CR21","doi-asserted-by":"publisher","first-page":"119932","DOI":"10.1016\/j.biomaterials.2020.119932","volume":"242","author":"H Ye","year":"2020","unstructured":"Ye H, Wang K, Lu Q, Zhao J, Wang M, Kan Q, et al. Nanosponges of circulating tumour-derived exosomes for breast cancer metastasis inhibition. Biomaterials. 2020;242:119932.","journal-title":"Biomaterials"},{"key":"1270_CR22","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1038\/s41467-021-22407-6","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Zhao Z, Qiu N, Zhou Q, Wang G, Jiang H, et al. Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy. Nat Commun. 2021;12:2425.","journal-title":"Nat Commun"},{"key":"1270_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biomaterials.2014.11.011","volume":"40","author":"JJ Mendez","year":"2015","unstructured":"Mendez JJ, Ghaedi M, Sivarapatna A, Dimitrievska S, Shao Z, Osuji CO, et al. Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant and accelerate wound healing in vivo. Biomaterials. 2015;40:61\u201371.","journal-title":"Biomaterials"},{"key":"1270_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H, et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol. 2019;14:89\u201397.","journal-title":"Nat Nanotechnol"},{"key":"1270_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"11","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11:125.","journal-title":"J Hematol Oncol"},{"key":"1270_CR26","doi-asserted-by":"publisher","first-page":"640578","DOI":"10.3389\/fimmu.2021.640578","volume":"12","author":"L Schmied","year":"2021","unstructured":"Schmied L, H\u00f6glund P, Meinke S. Platelet-mediated protection of cancer cells from immune surveillance\u2014possible implications for cancer immunotherapy. Front Immunol. 2021;12:640578.","journal-title":"Front Immunol"},{"key":"1270_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cmet.2020.12.006","volume":"33","author":"J Levoux","year":"2021","unstructured":"Levoux J, Prola A, Lafuste P, Gervais M, Chevallier N, Koumaiha Z, et al. Platelets facilitate the wound-healing capability of mesenchymal stem cells by mitochondrial transfer and metabolic reprogramming. Cell Metab. 2021;33:283-299.e9.","journal-title":"Cell Metab"},{"key":"1270_CR28","doi-asserted-by":"publisher","first-page":"120620","DOI":"10.1016\/j.biomaterials.2020.120620","volume":"269","author":"J Cao","year":"2021","unstructured":"Cao J, Yang P, Wang P, Xu S, Cheng Y, Qian K, et al. \u201cAdhesion and release\u201d nanoparticle-mediated efficient inhibition of platelet activation disrupts endothelial barriers for enhanced drug delivery in tumours. Biomaterials. 2021;269:120620.","journal-title":"Biomaterials"},{"key":"1270_CR29","first-page":"2001596","volume":"8","author":"H Li","year":"2021","unstructured":"Li H, Kuang X, Liang L, Ye Y, Zhang Y, Li J, et al. The Beneficial Role of Sunitinib in Tumour Immune Surveillance by Regulating Tumour PD-L1. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2021;8:2001596.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"1270_CR30","doi-asserted-by":"publisher","first-page":"120579","DOI":"10.1016\/j.biomaterials.2020.120579","volume":"268","author":"C Wang","year":"2021","unstructured":"Wang C, Shi X, Song H, Zhang C, Wang X, Huang P, et al. Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumour immunity against melanoma. Biomaterials. 2021;268:120579.","journal-title":"Biomaterials"},{"key":"1270_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer F, van Gulijk M, Mulder EE, Lukkes M, Klaase L, van den Bosch T, et al. The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumour-draining lymph nodes. Cancer Cell. 2020;38:685-700.e8.","journal-title":"Cancer Cell"},{"key":"1270_CR32","doi-asserted-by":"publisher","first-page":"120744","DOI":"10.1016\/j.biomaterials.2021.120744","volume":"271","author":"B Zhang","year":"2021","unstructured":"Zhang B, Jiang T, She XJ, Shen S, Wang S, Deng J, et al. Corrigendum to \u201cFibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumours in nude mice\u201d [Biomaterials (2016) 63\u201371]. Biomaterials. 2021;271:120744.","journal-title":"Biomaterials"},{"key":"1270_CR33","doi-asserted-by":"publisher","first-page":"120290","DOI":"10.1016\/j.biomaterials.2020.120290","volume":"259","author":"T Mei","year":"2020","unstructured":"Mei T, Shashni B, Maeda H, Nagasaki Y. Fibrinolytic tissue plasminogen activator installed redox-active nanoparticles (t-PA@iRNP) for cancer therapy. Biomaterials. 2020;259:120290.","journal-title":"Biomaterials"},{"key":"1270_CR34","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1038\/s41467-019-12771-9","volume":"10","author":"L Huang","year":"2019","unstructured":"Huang L, Li Y, Du Y, Zhang Y, Wang X, Ding Y, et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumours via an all-in-one and all-in-control strategy. Nat Commun. 2019;10:4871.","journal-title":"Nat Commun"},{"key":"1270_CR35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515:568\u201371.","journal-title":"Nature"},{"key":"1270_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bpj.2010.11.019","volume":"100","author":"RI Litvinov","year":"2011","unstructured":"Litvinov RI, Barsegov V, Schissler AJ, Fisher AR, Bennett JS, Weisel JW, et al. Dissociation of bimolecular \u03b1IIb\u03b23-fibrinogen complex under a constant tensile force. Biophys J. 2011;100:165\u201373.","journal-title":"Biophys J"},{"key":"1270_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1523-1755.2005.00436.x","volume":"68","author":"D Odobasic","year":"2005","unstructured":"Odobasic D, Kitching AR, Tipping PG, Holdsworth SR. CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms. Kidney Int. 2005;68:584\u201394.","journal-title":"Kidney Int"},{"key":"1270_CR38","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.4049\/jimmunol.161.6.2762","volume":"161","author":"AN Schweitzer","year":"1998","unstructured":"Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7\u20131 (CD80) and B7\u20132 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J Immunol. 1998;161:2762\u201371.","journal-title":"J Immunol"},{"key":"1270_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1074-7613(00)80323-4","volume":"5","author":"DJ Lenschow","year":"1996","unstructured":"Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY, et al. CD28\/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity. 1996;5:285\u201393.","journal-title":"Immunity"}],"updated-by":[{"DOI":"10.1186\/s12951-025-03867-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000}}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01270-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01270-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01270-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:02:01Z","timestamp":1770148921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-022-01270-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01270-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"6 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: fig. 5 has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12951-025-03867-0","URL":"https:\/\/doi.org\/10.1186\/s12951-025-03867-0","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animals adopted were in accordance with the requirements and regulations from the Animal Ethics Committee of Shenyang Pharmaceutical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}